Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell

Neuroscience Bulletin

Volumn 30, Issue 1, 2014, Pages 67-73

  Li, Hong ^a   Li, Zhe ^a   Xu, Ya Ming ^a   Wu, Yue ^a   Yu, Kang Kang ^a   Zhang, Can ^a   Ji, Yong Hua ^a   Ding, Gang ^b   Chen, Fu Xue ^a  

^a SHANGHAI UNIVERSITY   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

apoptosis; epigallocatechin 3 gallate; glioma; invasion; proliferation

Indexed keywords

EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; LAMININ RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEA; TUMOR INVASION; WESTERN BLOTTING;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GLIOMA; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9;

EID: 84895823824     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-013-1394-z     Document Type: Article

References (30)

1. Lisa M, DeAngelis MD. Brain tumors. N Engl J Med 2001, 344: 114-123.
2. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci 2001, 24: 385-428.
3. Louis DN OH, Wiestler OD, Cavenee WK, Burger PC, Jouvet A. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007, 114: 97-109.
4. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444: 756-760.
5. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 1993, 85: 704-710.
6. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci 2007, 81: 519-533.
7. Siddiqui IA, Shukla Y, Adhami VM, Sarfaraz S, Asim M, Hafeez BB, et al. Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm Res 2008, 25: 2135-2142.
8. Lesot H, Kühl U, Mark K. Isolation of a laminin-binding protein from muscle cell membranes. EMBO J 1983, 2: 861-865.
9. Malinoff HL, Wicha MS. Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol 1983, 96: 1475-1479.
10. Rao NC, Barsky SH, Terranova VP, Liotta LA. Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun 1983, 111: 804-808.
11. Yang Y, Qiu Y, Ren W, Gong J, Chen F. An identification of stem cell-resembling gene expression profiles in high-grade astrocytomas. Mol Carcinog 2008, 47: 893-903.
12. Chen FX, Qian YR, Duan YH, Ren WW, Yang Y, Zhang CC, et al. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro. Brain Res Bull 2009, 79: 402-408.
13. Sylvie Ménard ETaMC. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 1983, 52: 137-145.
14. Boukerche H, Su ZZ, Kang DC, Fisher PB. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridisation. Gene 2004, 343: 191-201.
15. Alberts AS. Identification of a carboxyl-terminal diaphanousrelated formin homology protein autoregulatory domain. J Bio Chem 2001, 276: 2824-2830.
16. Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004, 11: 380-381.
17. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2: 161-174.
18. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006, 25: 9-34.
19. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and antitargets for cancer therapy. Nat Rev Cancer 2006, 6: 227-239.
20. Siegelin M, Habel A, Gaiser T. Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma. Neurosci Lett 2008, 448: 161-165.
21. Choi YJ, Lim SY, Woo JH, Kim YH, Kwon YK, Suh SI, et al. Sodium orthovanadate potentiates EGCG-induced apoptosis that is dependent on the ERK pathway. Biochem Biophys Res Commun 2003, 305: 176-185.
22. Ahmad N FD, Nieminen AL, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 1997, 89: 1881-1886.
23. Rao SD, Pagidas K. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer Res 2010, 30: 2519-2523.
24. Thangapazham RL, Passi N, Maheshwari RK. Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells. Cancer Biol Ther 2007, 6: 1938-1943.
25. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavencc WK, et al. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 2001, 15: 1311-1333.
26. Gao Y, Li W, Jia L, Li B, Chen YC, Tu Y. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPCA-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways. Biochem Biophys Res Commun 2013, 438: 370-374.
27. Garzetti GG CA, Lucarini G, Goteri G, De Nicolis M, Garbisa S, Masiero L, et al. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarianserous cytstadenocarcinomas: clinical and prognostic implications. Anticancer Res 1995, 15: 2799-2804.
28. Stetler-Stevenson WG. The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin NAm 2001, 10: 383-392.
29. Gohji K, Fujimoto N, Hara I, Fujii A, Gotoh A, Okada H, et al. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 1998, 79: 96-101.
30. Blazquez C, Salazar M, Carracedo A, Lorente M, Egia A, Gonzalez-Feria L, et al. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res 2008, 68: 1945-1952.